Trials / Completed
CompletedNCT04442633
Glutamine With Topical Corticosteroids for Lichen Planus Treatment
Clinical Evaluation of Glutamine Combined With Topical Corticosteroids in the Treatment of Erosive Oral Lichen Planus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Hams Hamed Abdelrahman · Academic / Other
- Sex
- All
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Lichen planus (LP) is an inflammatory skin disease of unknown etiology. Glutamine promotes protein and collagen synthesis, imparts immunity, and maintains the alimentary canal mucosa structure.
Detailed description
Lichen planus (LP) is an inflammatory skin disease of unknown etiology. Recently, increased oxidative stress has been implicated in the pathogenesis of erosive oral lichen planus (EOLP). Glutamine is a source of energy for fibroblasts, immunocompetent cells, and intestinal epithelial cells involved in collagen production. It promotes protein and collagen synthesis, imparts immunity, and maintains the alimentary canal mucosa structure. The aim of this study is to evaluate the effect of Glutamine combined with topical corticosteroid in the treatment of oral erosive LP. Thirty patients with a confirmed clinical and histopathologic diagnosis of OLP recruited in this study and divided into 2 equal groups, each consisting of 15 subjects. Group 1 consists of patients treated with topical steroids plus antifungal (conventional therapy); Group 2 consists of patients treated with Glutamine combined with topical steroids plus antifungal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glutamine Cap/Tab | Glutamine Capsules: One capsule three times daily on an empty stomach for one month |
| DRUG | Miconazole Oral gel | Miconazole oral gel: applied three to four times daily for three weeks |
| DRUG | Kenacort in orabase | Kenacort in orabase: applied two to three times a day for 3 weeks followed by tapering the following 9 weeks until a maintenance dose of two to three times a week is reached |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2019-08-01
- Completion
- 2020-01-01
- First posted
- 2020-06-22
- Last updated
- 2020-06-22
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04442633. Inclusion in this directory is not an endorsement.